HIV & AIDS

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

Cardiology

Sharp decrease in deaths from sudden cardiac arrest

Only a few decades ago, sudden cardiac arrest was a death sentence. Today, a victim of sudden cardiac arrest is saved roughly once every six hours in Sweden, reveals a thesis from the Sahlgrenska Academy at the University ...

page 14 from 15